Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece.
Semin Cancer Biol. 2011 Nov;21(5):299-307. doi: 10.1016/j.semcancer.2011.09.009. Epub 2011 Sep 18.
Immunogenetic analysis of mantle cell lymphoma (MCL) has offered important evidence helping to decipher the immune pathways leading to its development and also prompting a reappraisal of the views about its ontogeny. In particular, older and more recent studies have demonstrated that MCL is characterized by a highly distinctive immunoglobulin gene repertoire with remarkable predominance of the IGHV3-21 and IGHV4-34 genes; restricted associations of IGHV, IGHD and IGHJ genes, culminating in the creation of quasi-identical ("stereotyped") heavy complementarity-determining region 3 sequences in roughly 10% of cases; and, very precisely targeted and, probably, functionally driven somatic hypermutation, ranging from minimal (in most cases) to pronounced. Furthermore, comparison to other entities, in particular CLL, revealed that several of these immunogenetic features are "MCL-biased". On these grounds, an antigen-driven origin of MCL could be envisaged, at least for subsets of cases.
套细胞淋巴瘤(MCL)的免疫遗传学分析为阐明导致其发生的免疫途径提供了重要证据,也促使人们重新审视对其发生的看法。特别是,较旧和较新的研究表明,MCL 的特征是具有高度独特的免疫球蛋白基因库,IGHV3-21 和 IGHV4-34 基因显著占优势;IGHV、IGHD 和 IGHJ 基因的受限关联,最终导致大约 10%的情况下产生准同源(“定型”)重互补决定区 3 序列;并且,非常精确地靶向和可能功能驱动的体细胞超突变,从最小(在大多数情况下)到明显。此外,与其他实体(特别是 CLL)相比,这些免疫遗传学特征中的几个是“MCL 偏向”的。基于这些理由,可以设想至少对于某些情况下的亚组,MCL 具有抗原驱动的起源。